GERN Q3 2020 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$108,000-17.6% YoY

Gross Profit

$108,000100.0% margin

Operating Income

-$20M-18532.4% margin

Net Income

-$20M-18195.4% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

+151.2%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$286M

Total Liabilities

$53M

Stockholders' Equity

$233M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$108,000	$131,000	-17.6%
Gross Profit	$108,000	-$11M	+101.0%
Operating Income	-$20M	-$16M	-25.3%
Net Income	-$20M	-$15M	-29.5%